HC Surgical Specialists Ltd
SGX:1B1
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.24
0.3
|
Price Target |
|
We'll email you a reminder when the closing price reaches SGD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one 1B1 stock under the Base Case scenario is 0.441 SGD. Compared to the current market price of 0.275 SGD, HC Surgical Specialists Ltd is Undervalued by 38%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
HC Surgical Specialists Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for 1B1 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
HC Surgical Specialists Ltd
Balance Sheet Decomposition
HC Surgical Specialists Ltd
Current Assets | 10.9m |
Cash & Short-Term Investments | 8.1m |
Receivables | 1.9m |
Other Current Assets | 933k |
Non-Current Assets | 17m |
Long-Term Investments | 9m |
PP&E | 4m |
Intangibles | 3.4m |
Other Non-Current Assets | 588k |
Current Liabilities | 10.5m |
Accounts Payable | 6.1m |
Other Current Liabilities | 4.5m |
Non-Current Liabilities | 2.6m |
Long-Term Debt | 1.9m |
Other Non-Current Liabilities | 750k |
Earnings Waterfall
HC Surgical Specialists Ltd
Revenue
|
18.8m
SGD
|
Cost of Revenue
|
-2.8m
SGD
|
Gross Profit
|
16m
SGD
|
Operating Expenses
|
-9.8m
SGD
|
Operating Income
|
6.2m
SGD
|
Other Expenses
|
-2.4m
SGD
|
Net Income
|
3.8m
SGD
|
Free Cash Flow Analysis
HC Surgical Specialists Ltd
SGD | |
Free Cash Flow | SGD |
1B1 Profitability Score
Profitability Due Diligence
HC Surgical Specialists Ltd's profitability score is 73/100. The higher the profitability score, the more profitable the company is.
Score
HC Surgical Specialists Ltd's profitability score is 73/100. The higher the profitability score, the more profitable the company is.
1B1 Solvency Score
Solvency Due Diligence
HC Surgical Specialists Ltd's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Score
HC Surgical Specialists Ltd's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
1B1 Price Targets Summary
HC Surgical Specialists Ltd
Dividends
Current shareholder yield for 1B1 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
HC Surgical Specialists Ltd. is an investment holding company, which engages in healthcare segment. The firm is engaged in the provision of endoscopic procedures, including gastroscopies and colonoscopies, and general surgery services. The firm focuses on colorectal procedures across a network of clinics located throughout Singapore. The company also provides medical care, consultancy, treatment and surgery in the field of colorectal endoscopy, vein and vascular. The firm treats a range of conditions, including hemorrhoids, anal abscesses, anal fissures, gallstones and inflammation of the gallbladder, hernias, colorectal cancer, stomach cancer, colonic diverticular disease, and cysts and lipomas. The firm's clinics are located in central Singapore, as well as, in residential areas, including the heartlands. The firm operates a wide network of clinics located throughout Singapore, in both residential areas and central areas, which are accessible to the public for consultation.
Contact
IPO
Employees
Officers
The intrinsic value of one 1B1 stock under the Base Case scenario is 0.441 SGD.
Compared to the current market price of 0.275 SGD, HC Surgical Specialists Ltd is Undervalued by 38%.